Dongping Wei

1.7k total citations
33 papers, 1.2k citations indexed

About

Dongping Wei is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Dongping Wei has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Dongping Wei's work include Ubiquitin and proteasome pathways (12 papers), Cancer-related Molecular Pathways (8 papers) and Cancer Research and Treatments (5 papers). Dongping Wei is often cited by papers focused on Ubiquitin and proteasome pathways (12 papers), Cancer-related Molecular Pathways (8 papers) and Cancer Research and Treatments (5 papers). Dongping Wei collaborates with scholars based in China, United States and Australia. Dongping Wei's co-authors include Yi Sun, Lili Zhao, Meredith A. Morgan, Theodore S. Lawrence, Leslie A. Parsels, Jonathan Maybaum, David Karnak, Mary A. Davis, Lijun Jia and Yongchao Zhao and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Dongping Wei

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongping Wei China 21 870 472 198 164 151 33 1.2k
Jennifer M. Rosenbluth United States 15 621 0.7× 597 1.3× 296 1.5× 76 0.5× 135 0.9× 28 1.1k
Julie Bianchi United Kingdom 14 1.4k 1.6× 641 1.4× 401 2.0× 75 0.5× 125 0.8× 22 1.8k
Doris A. Phelps United States 20 832 1.0× 362 0.8× 197 1.0× 86 0.5× 58 0.4× 36 1.3k
Magali Rebucci France 9 509 0.6× 410 0.9× 312 1.6× 93 0.6× 61 0.4× 11 935
Mingqian Feng China 18 598 0.7× 360 0.8× 109 0.6× 125 0.8× 89 0.6× 49 1.3k
Wendy L. Devereux United States 13 1.1k 1.3× 450 1.0× 140 0.7× 92 0.6× 51 0.3× 13 1.4k
Futoshi Uno Japan 20 784 0.9× 579 1.2× 200 1.0× 409 2.5× 97 0.6× 46 1.4k
Tawnya L. Bowles United States 14 325 0.4× 400 0.8× 195 1.0× 257 1.6× 116 0.8× 36 835
Cheryl Zimberlin Netherlands 9 650 0.7× 708 1.5× 264 1.3× 104 0.6× 24 0.2× 10 1.2k
Hyang Sook Seol South Korea 15 327 0.4× 288 0.6× 228 1.2× 76 0.5× 84 0.6× 22 754

Countries citing papers authored by Dongping Wei

Since Specialization
Citations

This map shows the geographic impact of Dongping Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongping Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongping Wei more than expected).

Fields of papers citing papers by Dongping Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongping Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongping Wei. The network helps show where Dongping Wei may publish in the future.

Co-authorship network of co-authors of Dongping Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Dongping Wei. A scholar is included among the top collaborators of Dongping Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongping Wei. Dongping Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Liang, et al.. (2024). Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and lung cancer metastasis.. Journal of Clinical Oncology. 42(16_suppl). e20520–e20520. 1 indexed citations
2.
Liu, Liang, Xiaohong Chen, Leilei Wu, et al.. (2024). Ubiquitin ligase subunit FBXO9 inhibits V-ATPase assembly and impedes lung cancer metastasis. Experimental Hematology and Oncology. 13(1). 32–32. 7 indexed citations
3.
Wu, Leilei, et al.. (2023). LINC01572 is a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma. Frontiers in Bioscience-Landmark. 28(10). 257–257. 2 indexed citations
4.
Zhou, Shuai, Ran Xu, Dongping Wei, et al.. (2022). TRIM27 cooperates with STK38L to inhibit ULK1‐mediated autophagy and promote tumorigenesis. The EMBO Journal. 41(14). e109777–e109777. 39 indexed citations
5.
Zhang, Qiang, Dongping Wei, Mingjia Tan, et al.. (2020). Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras–PDAC model. Neoplasia. 22(6). 242–252. 8 indexed citations
6.
Cui, Danrui, Xiao-Qing Dai, Jianfeng Shu, et al.. (2019). The cross talk of two family members of β-TrCP in the regulation of cell autophagy and growth. Cell Death and Differentiation. 27(3). 1119–1133. 38 indexed citations
7.
Chen, Xiaoyu, Xiufang Xiong, Danrui Cui, et al.. (2019). DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 39(7). 1557–1571. 36 indexed citations
8.
Liu, Zhiyi, Li Zhang, Zhaozhi Yang, et al.. (2018). Targeting deubiquitinase USP28 for cancer therapy. Cell Death and Disease. 9(2). 186–186. 80 indexed citations
9.
Wei, Dongping, Qiang Zhang, Leslie A. Parsels, et al.. (2015). Targeting Mcl-1 for Radiosensitization of Pancreatic Cancers. Translational Oncology. 8(1). 47–54. 23 indexed citations
10.
Zheng, Wang, Songtao Lai, Ningyi Ma, et al.. (2015). Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair. Cancer Letters. 369(1). 192–201. 44 indexed citations
11.
Karnak, David, Carl G. Engelke, Leslie A. Parsels, et al.. (2014). Combined Inhibition of Wee1 and PARP1/2 for Radiosensitization in Pancreatic Cancer. Clinical Cancer Research. 20(19). 5085–5096. 125 indexed citations
12.
Xu, Junfeng, Lihui Li, Guangyang Yu, et al.. (2014). The Neddylation-Cullin 2-RBX1 E3 Ligase Axis Targets Tumor Suppressor RhoB for Degradation in Liver Cancer. Molecular & Cellular Proteomics. 14(3). 499–509. 46 indexed citations
13.
Wei, Dongping, Leslie A. Parsels, David Karnak, et al.. (2013). Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair. Clinical Cancer Research. 19(16). 4422–4432. 80 indexed citations
14.
Engelke, Carl G., Leslie A. Parsels, Yushen Qian, et al.. (2013). Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776. Clinical Cancer Research. 19(16). 4412–4421. 89 indexed citations
15.
Wei, Dongping, Hua Li, Jie Yu, et al.. (2011). Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor. Cancer Research. 72(1). 282–293. 136 indexed citations
16.
Chen, Jianxiang, Dongping Wei, Hongqin Zhuang, et al.. (2011). Proteomic Screening of Anaerobically Regulated Promoters from Salmonella and Its Antitumor Applications. Molecular & Cellular Proteomics. 10(6). M111.009399–M111.009399. 28 indexed citations
17.
Chen, Guo, Dongping Wei, Bo Tang, et al.. (2009). Oral delivery of tumor‐targeting Salmonella exhibits promising therapeutic efficacy and low toxicity. Cancer Science. 100(12). 2437–2443. 39 indexed citations
18.
Sun, Qiming, Dongping Wei, Jiahuang Li, et al.. (2007). A novel ferritin gene, SferH‐5, reveals heterogeneity of the 26.5‐kDa subunit of soybean (Glycine max) seed ferritin. FEBS Letters. 581(30). 5796–5802. 9 indexed citations
19.
Jia, Lijun, et al.. (2007). Oral delivery of tumor‐targeting Salmonella for cancer therapy in murine tumor models. Cancer Science. 98(7). 1107–1112. 52 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer M. Rosenbluth Breakdown of academic impact, for papers by Julie Bianchi Breakdown of academic impact, for papers by Doris A. Phelps Breakdown of academic impact, for papers by Magali Rebucci Breakdown of academic impact, for papers by Mingqian Feng Breakdown of academic impact, for papers by Wendy L. Devereux Breakdown of academic impact, for papers by Futoshi Uno Breakdown of academic impact, for papers by Tawnya L. Bowles Breakdown of academic impact, for papers by Cheryl Zimberlin Breakdown of academic impact, for papers by Hyang Sook Seol
Rankless by CCL
2026